$IPWR
Ideal Power Inc. Stock $ipwr

$ipwr Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114420415064967 Filed on November 13, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$970.0K	$895.5K	$438.0K
YoY Change	94.0%	104.44%	-27.98%
Cost Of Revenue	$950.0K	$842.4K	$533.5K
YoY Change	55.74%	57.89%	-13.93%
Gross Profit	$10.00K	$53.07K	-$95.51K
YoY Change	-109.09%	-155.56%	717.34%
Gross Profit Margin	1.03%	5.93%	-21.8%
Selling, General & Admin	$1.350M	$1.267M	$1.074M
YoY Change	19.47%	17.97%	87.99%
% of Gross Profit	13500.0%	2386.71%
Research & Development	$1.710M	$1.717M	$689.4K
YoY Change	122.08%	149.03%	164.08%
% of Gross Profit	17100.0%	3235.24%
Depreciation & Amortization	$90.00K	$60.00K	$20.00K
YoY Change	200.0%	200.0%	100.0%
% of Gross Profit	900.0%	113.07%
Operating Expenses	$3.060M	$2.983M	$1.763M
YoY Change	61.05%	69.22%	111.86%
Operating Profit	-$3.050M	-$2.930M	-$1.858M
YoY Change	51.74%	57.67%	120.24%
Interest Expense	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	0.0%	-100.76%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.040M	-$2.920M	-$1.850M
YoY Change	52.0%	57.84%	-14.35%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$3.040M	-$2.918M	-$1.852M
YoY Change	52.0%	57.58%	-14.46%
Net Earnings / Revenue	-313.4%	-325.88%	-422.77%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.234M	-$3.106M	-$2.643M
COMMON SHARES
Basic Shares Outstanding	9.400M shares		7.015M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.02M	$17.33M	$9.730M
YoY Change	89.89%	78.11%	3375.0%
Cash & Equivalents	$15.02M	$17.33M	$9.730M
Short-Term Investments
Other Short-Term Assets	$68.00K	$170.0K	$110.0K
YoY Change	-32.44%	54.55%	-76.6%
Inventory	$648.0K	$586.1K	$343.9K
Prepaid Expenses
Receivables	$872.9K	$795.6K	$399.8K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$16.84M	$18.87M	$10.58M
YoY Change	89.77%	78.39%	403.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$925.9K	$854.3K	$331.2K
YoY Change	147.32%	157.92%	728.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.92K	$17.92K	$35.84K
YoY Change	0.0%	-50.0%
Total Long-Term Assets	$2.411M	$2.160M	$1.279M
YoY Change	71.54%	68.86%	96.82%
TOTAL ASSETS
Total Short-Term Assets	$16.84M	$18.87M	$10.58M
Total Long-Term Assets	$2.411M	$2.160M	$1.279M
Total Assets	$19.25M	$21.04M	$11.86M
YoY Change	87.28%	77.36%	331.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.339M	$1.034M	$429.4K
YoY Change	203.15%	140.75%	-70.18%
Accrued Expenses	$1.240M	$1.093M	$741.8K
YoY Change	60.4%	47.39%	80.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.579M	$2.127M	$1.171M
YoY Change	112.3%	81.62%	-82.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.579M	$2.127M	$1.171M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$2.579M	$2.130M	$1.170M
YoY Change	113.13%	82.05%	-84.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.09M	-$31.06M	-$21.65M
YoY Change	44.14%	43.43%
Common Stock	$9.550K	$9.380K	$7.022K
YoY Change	35.5%	33.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.657K	$2.657K	$2.657K
YoY Change	0.0%	0.0%
Treasury Stock Shares	1.000K shares
Shareholders Equity	$16.67M	$18.91M	$10.69M
YoY Change
Total Liabilities & Shareholders Equity	$19.25M	$21.04M	$11.86M
YoY Change	87.28%	77.36%	331.27%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$3.040M	-$2.918M	-$1.852M
YoY Change	52.0%	57.58%	-14.46%
Depreciation, Depletion And Amortization	$90.00K	$60.00K	$20.00K
YoY Change	200.0%	200.0%	100.0%
Cash From Operating Activities	-$2.350M	-$2.220M	-$1.320M
YoY Change	42.42%	68.18%	100.0%
INVESTING ACTIVITIES
Capital Expenditures	-$380.0K	-$500.0K	-$100.0K
YoY Change	123.53%	400.0%	150.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$380.0K	-$500.0K	-$100.0K
YoY Change	123.53%	400.0%	150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	420.0K	90.00K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-2.350M	-2.220M	-1.320M
Cash From Investing Activities	-380.0K	-500.0K	-100.0K
Cash From Financing Activities	420.0K	90.00K	0.000
Net Change In Cash	-2.310M	-2.630M	-1.420M
YoY Change	26.92%	85.21%	1477.78%
FREE CASH FLOW
Cash From Operating Activities	-$2.350M	-$2.220M	-$1.320M
Capital Expenditures	-$380.0K	-$500.0K	-$100.0K
Free Cash Flow	-$1.970M	-$1.720M	-$1.220M
YoY Change	33.11%	40.98%	96.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Assets Assets	21035135	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	374376	USD
CY2015Q3	us-gaap	Revenues Revenues	895490	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2127217	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17920	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17920	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	8873475	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1214755	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	854280	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1288010	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1012964	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	18874925	USD
CY2014Q4	us-gaap	Assets Assets	10278735	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	441636	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	402445	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	313766	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1033854	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17326588	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	166634	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	263605	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1093363	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	446521	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	773119	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7912011	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	795559	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	586144	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	251338	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	533535	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	-95506	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	689396	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	762741	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	310818	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	1762955	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1858461	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6617	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-1851844	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7015156	shares
CY2015Q3	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2014Q3	us-gaap	Revenue From Grants RevenueFromGrants	149029	USD
CY2014Q3	us-gaap	Revenues Revenues	438029	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	842425	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	367947	USD
CY2015Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	0	USD
CY2014Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	165588	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	9380	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	7048	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49957213	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32712020	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2657	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2657	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31056018	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23652431	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	18907918	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	9063980	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21035135	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10278735	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	895490	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	289000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	842425	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	53065	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1716782	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	888132	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	378378	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	2983292	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2930227	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12028	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-2918199	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9356195	shares
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3292518	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	841600	USD
	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
	us-gaap	Revenue From Grants RevenueFromGrants	448050	USD
	us-gaap	Revenues Revenues	3292518	USD
	us-gaap	Revenues Revenues	1289650	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2918064	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1003260	USD
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	0	USD
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	497833	USD
	us-gaap	Cost Of Revenue CostOfRevenue	2918064	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1501093	USD
	us-gaap	Gross Profit GrossProfit	374454	USD
CY2015Q3	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	39468	USD
CY2015Q3	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	159941	USD
	us-gaap	Gross Profit GrossProfit	-211443	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3809362	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1644294	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2767273	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2225996	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1222558	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	840565	USD
	us-gaap	Operating Expenses OperatingExpenses	7799193	USD
	us-gaap	Operating Expenses OperatingExpenses	4710855	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7424739	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4922298	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21152	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	22148	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7403587	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4900150	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.91
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8180137	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7008634	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	144834	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43248	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-2156	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	109788	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1012825	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	597055	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	76410	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	101879	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	403829	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	147363	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	348677	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-175746	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-96971	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-88956	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	592218	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-109717	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	320244	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	280610	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5704527	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3819732	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	636741	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	278318	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1039186	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-592084	USD
	ipwr	Proceeds From Payments For Exercise Of Options And Warrants ProceedsFromPaymentsForExerciseOfOptionsAndWarrants	233885	USD
	ipwr	Proceeds From Payments For Exercise Of Options And Warrants ProceedsFromPaymentsForExerciseOfOptionsAndWarrants	4987	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16158290	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4987	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9414577	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4406829	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14137097	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9730268	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	54791	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15924405	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Noncash Project Abandonment Costs NoncashProjectAbandonmentCosts	45641	USD
	us-gaap	Noncash Project Abandonment Costs NoncashProjectAbandonmentCosts	0	USD
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2013-07-15
CY2015Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2015Q3	ipwr	Trade Receivables Current TradeReceivablesCurrent	716846	USD
CY2014Q4	ipwr	Trade Receivables Current TradeReceivablesCurrent	231412	USD
CY2015Q3	us-gaap	Grants Receivable Current GrantsReceivableCurrent	0	USD
CY2014Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	132227	USD
CY2015Q3	us-gaap	Other Receivables OtherReceivables	78713	USD
CY2014Q4	us-gaap	Other Receivables OtherReceivables	107657	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24775	USD
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	79566	USD
CY2014	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	24775	USD
CY2015Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	261707	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	143289	USD
CY2015Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	328711	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	148752	USD
CY2015Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4274	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	40703	USD
CY2015Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	594363	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	263142	USD
CY2015Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	318545	USD
CY2014Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	48280	USD
CY2015Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	181486	USD
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	183237	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	240114	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	120283	USD
CY2015Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1243564	USD
CY2014Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1040219	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	44866	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27255	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	538189	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	548953	USD
CY2015Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	312721	USD
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	143364	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	242453	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	80802	USD
CY2015Q3	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	163489	USD
CY2015Q3	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	68736	USD
CY2015Q3	us-gaap	Other Commitment OtherCommitment	431634	USD
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2017-05-31
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	161929	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	86949	USD
CY2015Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	54552	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	50176	USD
	ipwr	Gross Proceeds From Issuance Of Common Stock GrossProceedsFromIssuanceOfCommonStock	17250000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1000000	USD
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3000	shares
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3308041	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
	ipwr	Research And Development Expense Including Grants ResearchAndDevelopmentExpenseIncludingGrants	497833	USD
CY2014Q3	ipwr	Research And Development Expense Including Grants ResearchAndDevelopmentExpenseIncludingGrants	165588	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3061810	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2940635	shares
	dei	Document Type DocumentType	10-Q
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	IPWR
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9400043	shares
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	Ideal Power Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001507957
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9379939	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9379939	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7048235	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7048235	shares
	ipwr	Stock Compensation Earned But Not Issued StockCompensationEarnedButNotIssued	0	USD
	ipwr	Stock Compensation Earned But Not Issued StockCompensationEarnedButNotIssued	50004	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, accounts receivable and accounts payable. The Company maintains its cash with a major financial institution located in the United States. Balances are insured by the Federal Deposit Insurance Corporation up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. The Company maintains balances in excess of federally insured limits. The Company has not experienced losses in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company encounters a certain amount of risk as a result of a concentration of revenue from a few significant customers. Credit is extended to customers based on an evaluation of their financial condition. In limited instances, the Company may require an upfront deposit and, in most cases, the Company does charge interest on past due amounts. The Company performs ongoing credit evaluations of its customers and records an allowance for potential bad debts based on available information. </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company had revenue from two customers which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 55</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12</font>% of net revenue for the three months ended September 30, 2015 and revenue from four customers which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 29</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 22</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 13</font>% of net revenue for the nine months ended September 30, 2015. The Company had receivable balances from two customers that accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 83</font>% of trade receivables at September 30, 2015.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	straight-line method
CY2015Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	795559	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	471296	USD
CY2015Q3	us-gaap	Inventory Gross InventoryGross	590418	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	292041	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1094394	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	494659	USD
CY2015Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	89312	USD
CY2014Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	0	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1332876	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1040219	USD
CY2015Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	24124	USD
CY2015Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	10000	shares
CY2015Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	77700	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	2428	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10000	shares
	dei	Entity Incorporation State Country Name EntityIncorporationStateCountryName	Delaware

Files In Submission

Name	View Source	Status
0001144204-15-064967-index-headers.html	Edgar Link	pending
0001144204-15-064967-index.html	Edgar Link	pending
0001144204-15-064967.txt	Edgar Link	pending
0001144204-15-064967-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
ipwr-20150930.xml	Edgar Link	completed
ipwr-20150930.xsd	Edgar Link	pending
ipwr-20150930_cal.xml	Edgar Link	unprocessable
ipwr-20150930_def.xml	Edgar Link	unprocessable
ipwr-20150930_lab.xml	Edgar Link	unprocessable
ipwr-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v424081_10q.htm	Edgar Link	pending
v424081_ex10-1.htm	Edgar Link	pending
v424081_ex31-1.htm	Edgar Link	pending
v424081_ex31-2.htm	Edgar Link	pending
v424081_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IPWR
Ideal Power Inc. Stock $ipwr

2015 Q4 Form 10-Q Financial Statement

#000114420415064967 Filed on November 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPWR Ideal Power Inc. Stock $ipwr

2015 Q4 Form 10-Q Financial Statement

#000114420415064967 Filed on November 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPWR
Ideal Power Inc. Stock $ipwr